Uses, Dosage & Side Effects: Jakafi Tablet
Jakafi Tablet
| Generic name | ruxolitinib |
|---|---|
| Drug class | Antineoplastic Janus kinase (JAK) inhibitors |
| Forms | Oral tablets (5 mg, 10 mg, 15 mg, 20 mg, 25 mg), Extended-release tablets, Jakafi XR (11 mg, 22 mg, 33 mg, 44 mg, 55 mg) |
Jakafi is a prescription medicine taken by mouth. It is used to treat certain blood cancers and immune problems that can happen after a stem cell transplant. It belongs to a group of medicines called kinase inhibitors, also known as JAK inhibitors.
Read the full guideUses, dosage, side effects, precautions, and sources, written from the same verified facts.
General information, not medical advice
Your prescriber and the leaflet in your pack know your situation. This page does not.
- Follow your prescriber and the leaflet
- Don't start, stop, or change a dose on your own
- Doses and warnings differ by country and product
Took too much, or feel seriously unwell? Get urgent medical help now.
Facts checked by a personFull disclaimer
